by Jason Fairchild | May 6, 2024
The overall goal in the laboratory is to discover and understand the functions of important mediators and effectors involved in innate and adaptive immunity. Of particular interest are cellular components and regulatory networks that interact dynamically within...
by Jason Fairchild | May 6, 2024
Deborah Wexler is the Associate Director of the BADERC and leads the Pilot and Feasibility Program. She is Chief of the Diabetes Unit at MGH and Associate Professor of Medicine at Harvard Medical School. Through her research and mentorship, Dr. Wexler aims to define...
by Jason Fairchild | May 6, 2024
Our team’s research aims to identify molecular subtypes of type 2 diabetes in order to improve patient management. We interrogate genetic data across the spectrum from rare to common variation to identify novel diabetes genes and mechanisms of disease. At the rare end...
by Jason Fairchild | May 6, 2024
Research in the Rosenzweig laboratory is focused identifying new mechanisms and targets in heart failure. Heart failure is closely related to metabolic dysregulation in general and diabetes in particular. In addition to studying what goes wrong in heart disease, a...
by Jason Fairchild | May 6, 2024
One of my lab’s major interests is the application of LC-MS based metabolomics to epidemiologic and physiologic studies of kidney disease, including diabetic nephropathy. We have spearheaded the first published studies of metabolomics to study the effects of the...
